5-Azacytidine : 5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline
MLN2480: Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers
5-Azacytidine : 5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline
MLN2480: Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers